The i-Lab Innovation Competition, led by the French Ministry of Higher Education and Research, is a flagship national program designed to support high-impact deeptech projects emerging from public research. Its objective is to accelerate the development of breakthrough technologies with strong industrial and societal potential, particularly in healthcare.
In 2023, Beams was awarded the i-Lab label in the Medical Technologies category. This recognition reflects several years of research and development at the intersection of nuclear medicine, physics, and clinical practice, as well as sustained collaboration with academic and hospital partners.
Beyond funding, i-Lab plays a key role in helping early-stage deeptech startups cross a critical threshold: moving from laboratory innovation to pre-industrial and clinical-ready solutions. For medical technologies, where validation cycles are long and highly regulated, this support is essential.
Being selected in 2023 marks an important step in the project’s trajectory and reinforces the ambition to translate advanced scientific research into technologies that can improve surgical precision and patient outcomes.
Explore the latest advances, clinical insights, and technology shaping the future of intraoperative tumor detection. Stay informed with expert perspectives from Beams and our partners.
Back to news
Beams’ co-founder and president, Virginie Simon, was recently profiled by Les Deeptech, an initiative of Bpifrance highlighting deeptech leaders. The feature shares Virginie’s inspiring journey and the vision driving Beams as it develops innovative tools to transform intraoperative cancer care.
Read article
As part of the 10th anniversary of the 3DEXPERIENCE Lab acceleration program, Beams was invited to present its technology on BFM Business. This opportunity allowed us to share our mission, our scientific roots, and our approach to improving surgical precision through real-time intraoperative tumor detection.
Read article
In 2023, CNRS Île-de-France published an article highlighting Beams’ work on developing a new tool to improve the completeness of tumor ablations during surgery. This recognition underscores the strong scientific roots of the project and its contribution to advancing precision in surgical oncology.
Read article
In 2023, Beams was selected in the Challenges magazine list of the 100 startups to invest in, a benchmark ranking highlighting the most promising French technology ventures. This recognition underscores the relevance of Beams’ scientific approach and its long-term potential in medical and nuclear technologies.
Read article
In 2023, Challenges magazine published a dedicated article highlighting Beams’ work in developing intelligent technologies to improve cancer treatment. This media coverage reflects the growing recognition of Beams’ approach at the intersection of science, healthcare, and deeptech innovation.
Read article
In 2023, Université Paris-Saclay published an article highlighting Beams’ work in medical technologies serving surgical oncology. This recognition emphasizes the strong scientific foundations of the project and its roots in academic research translated into clinical innovation.
Read article
In 2023, Techniques de l’Ingénieur published an article highlighting Beams’ work on real-time detection of tumor tissues during surgery. This coverage emphasizes the technological and scientific foundations of the solution, as well as its potential impact on surgical oncology.
Read article